Paul Daruwala Cidara Therapeutics, Inc. (CDTX) insider trading activity

Paul Daruwala is Chief Operating Officer of Cidara Therapeutics, Inc.. Currently has a direct ownership of 221,099 shares of CDTX, which is worth approximately $3.9 Million. The most recent transaction as insider was on Sep 12, 2022, when has been sold 16,199 shares (Common Stock) at a price of $0.68 per share, resulting in proceeds of $11,015. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 221K

0% 3M change

0% 12M change

Total Value Held $3.9 Million

Paul Daruwala Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 12 2022	SELL Open market or private sale	$11,015 $0.68 p/Share	16,199 Reduced 6.83%	221,099 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	50,000 Added 17.4%	237,298 Common Stock
Jan 05 2022	SELL Open market or private sale	$6,416 $1.25 p/Share	5,133 Reduced 2.67%	187,298 Common Stock
Dec 29 2021	BUY Exercise of conversion of derivative security	-	9,900 Added 4.89%	192,431 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	-	132,000 Added 41.97%	182,531 Common Stock
Apr 01 2021	SELL Open market or private sale	$1,577 $2.66 p/Share	593 Reduced 1.16%	50,531 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	-	1,400 Added 2.67%	51,124 Common Stock
Jan 05 2021	SELL Open market or private sale	$5,908 $2.06 p/Share	2,868 Reduced 5.45%	49,724 Common Stock

Paul Daruwala

Chief Operating Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDTX shares.

Notify only if

Value

Insider Trading

Get notified when an Cidara Therapeutics, Inc. insider buys or sells CDTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cidara Therapeutics, Inc.

Track Activities on CDTX

Account